Microbot Historical Balance Sheet

MBOT Stock

USD 1.52 0.04 2.56%

Trend analysis of Microbot Medical balance sheet accounts such as Total Current Liabilities of 4.8 M provides information on Microbot Medical's total assets, liabilities, and equity, which is the actual value of Microbot Medical to its prevalent stockholders. By breaking down trends over time using Microbot Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Microbot Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Microbot Medical is a good buy for the upcoming year.

Microbot Medical Inventory

(39,690)

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

About Microbot Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Microbot Medical at a specified time, usually calculated after every quarter, six months, or one year. Microbot Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Microbot Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Microbot currently owns. An asset can also be divided into two categories, current and non-current.

Microbot Medical Balance Sheet Chart

At this time, Microbot Medical's Property Plant Equipment is comparatively stable compared to the past year. Capital Lease Obligations is likely to gain to about 432.7 K in 2025, whereas Other Current Liabilities is likely to drop slightly above 2.6 M in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Microbot Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Microbot Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Microbot Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Microbot Medical are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Microbot Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Microbot Medical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.At this time, Microbot Medical's Property Plant Equipment is comparatively stable compared to the past year. Capital Lease Obligations is likely to gain to about 432.7 K in 2025, whereas Other Current Liabilities is likely to drop slightly above 2.6 M in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	462K	231K	207.9K	197.5K
Total Assets	9.5M	8.3M	7.5M	7.1M

Short Long Term Debt Total Total Assets

Microbot Medical balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Property Plant And Equipment Gross	Common Stock Total Equity	Common Stock	Short Term Investments	Current Deferred Revenue
Total Assets		0.57	0.31	0.56	0.65	0.69	-0.75	-0.61	0.03	0.9	0.74	0.55	0.97	-0.24	-0.49	0.72	0.54	0.64	0.7	0.98	0.58	0.37	0.39	0.36	0.01	-0.18
Short Long Term Debt Total	0.57		0.7	0.85	-0.13	0.94	-0.1	-0.76	-0.03	0.61	0.68	0.12	0.47	-0.1	-0.47	0.84	0.09	0.75	0.88	0.47	0.96	0.52	0.48	0.46	-0.39	-0.25
Other Current Liab	0.31	0.7		0.9	-0.46	0.74	0.31	-0.87	0.35	0.12	0.69	0.36	0.12	0.14	-0.3	0.77	-0.12	0.86	0.84	0.15	0.59	0.29	0.6	0.62	-0.22	-0.47
Total Current Liabilities	0.56	0.85	0.9		-0.19	0.86	0.0	-0.86	0.28	0.45	0.74	0.4	0.42	0.12	-0.33	0.83	0.21	0.86	0.92	0.44	0.79	0.38	0.56	0.56	-0.31	-0.41
Total Stockholder Equity	0.65	-0.13	-0.46	-0.19		-0.02	-0.93	0.16	-0.17	0.68	0.07	0.26	0.78	-0.25	-0.07	-0.05	0.63	-0.12	-0.09	0.77	-0.07	0.04	-0.17	-0.2	0.25	0.17
Property Plant And Equipment Net	0.69	0.94	0.74	0.86	-0.02		-0.18	-0.85	0.14	0.65	0.83	0.36	0.55	-0.16	-0.55	0.89	0.12	0.85	0.92	0.57	0.86	0.64	0.63	0.62	-0.22	-0.19
Net Debt	-0.75	-0.1	0.31	0.0	-0.93	-0.18		-0.02	0.01	-0.85	-0.23	-0.36	-0.84	0.35	0.29	-0.14	-0.66	-0.01	-0.11	-0.84	-0.15	-0.17	-0.03	0.01	-0.04	-0.18
Retained Earnings	-0.61	-0.76	-0.87	-0.86	0.16	-0.85	-0.02		-0.25	-0.39	-0.91	-0.56	-0.44	0.07	0.53	-0.95	-0.01	-1.0	-0.96	-0.45	-0.68	-0.37	-0.77	-0.77	0.14	0.47
Accounts Payable	0.03	-0.03	0.35	0.28	-0.17	0.14	0.01	-0.25		-0.02	0.34	0.64	-0.08	0.07	-0.17	0.14	-0.07	0.25	0.19	-0.08	-0.07	0.2	0.56	0.58	0.05	0.06
Cash	0.9	0.61	0.12	0.45	0.68	0.65	-0.85	-0.39	-0.02		0.55	0.35	0.93	-0.31	-0.46	0.55	0.57	0.41	0.55	0.92	0.63	0.41	0.27	0.24	-0.17	0.01
Non Current Assets Total	0.74	0.68	0.69	0.74	0.07	0.83	-0.23	-0.91	0.34	0.55		0.67	0.58	-0.15	-0.64	0.95	0.07	0.92	0.91	0.58	0.64	0.48	0.77	0.76	-0.02	-0.28
Non Currrent Assets Other	0.55	0.12	0.36	0.4	0.26	0.36	-0.36	-0.56	0.64	0.35	0.67		0.43	-0.3	-0.56	0.49	0.39	0.57	0.49	0.46	0.05	0.22	0.76	0.75	0.13	-0.09
Cash And Short Term Investments	0.97	0.47	0.12	0.42	0.78	0.55	-0.84	-0.44	-0.08	0.93	0.58	0.43		-0.23	-0.38	0.57	0.58	0.47	0.54	0.99	0.51	0.29	0.21	0.18	0.04	-0.12
Net Receivables	-0.24	-0.1	0.14	0.12	-0.25	-0.16	0.35	0.07	0.07	-0.31	-0.15	-0.3	-0.23		0.73	-0.13	-0.21	-0.04	-0.09	-0.25	-0.01	-0.14	-0.29	-0.23	0.01	-0.22
Common Stock Shares Outstanding	-0.49	-0.47	-0.3	-0.33	-0.07	-0.55	0.29	0.53	-0.17	-0.46	-0.64	-0.56	-0.38	0.73		-0.63	-0.13	-0.51	-0.57	-0.39	-0.4	-0.5	-0.66	-0.59	-0.07	-0.21
Non Current Liabilities Total	0.72	0.84	0.77	0.83	-0.05	0.89	-0.14	-0.95	0.14	0.55	0.95	0.49	0.57	-0.13	-0.63		0.06	0.95	0.98	0.56	0.8	0.44	0.7	0.68	-0.15	-0.36
Other Current Assets	0.54	0.09	-0.12	0.21	0.63	0.12	-0.66	-0.01	-0.07	0.57	0.07	0.39	0.58	-0.21	-0.13	0.06		0.03	0.13	0.64	0.07	-0.02	-0.02	-0.06	-0.13	0.0
Other Stockholder Equity	0.64	0.75	0.86	0.86	-0.12	0.85	-0.01	-1.0	0.25	0.41	0.92	0.57	0.47	-0.04	-0.51	0.95	0.03		0.96	0.48	0.68	0.37	0.76	0.76	-0.13	-0.47
Total Liab	0.7	0.88	0.84	0.92	-0.09	0.92	-0.11	-0.96	0.19	0.55	0.91	0.49	0.54	-0.09	-0.57	0.98	0.13	0.96		0.55	0.83	0.44	0.68	0.67	-0.21	-0.39
Total Current Assets	0.98	0.47	0.15	0.44	0.77	0.57	-0.84	-0.45	-0.08	0.92	0.58	0.46	0.99	-0.25	-0.39	0.56	0.64	0.48	0.55		0.5	0.29	0.23	0.2	0.02	-0.12
Short Term Debt	0.58	0.96	0.59	0.79	-0.07	0.86	-0.15	-0.68	-0.07	0.63	0.64	0.05	0.51	-0.01	-0.4	0.8	0.07	0.68	0.83	0.5		0.48	0.36	0.35	-0.33	-0.24
Property Plant And Equipment Gross	0.37	0.52	0.29	0.38	0.04	0.64	-0.17	-0.37	0.2	0.41	0.48	0.22	0.29	-0.14	-0.5	0.44	-0.02	0.37	0.44	0.29	0.48		0.33	0.3	0.38	0.58
Common Stock Total Equity	0.39	0.48	0.6	0.56	-0.17	0.63	-0.03	-0.77	0.56	0.27	0.77	0.76	0.21	-0.29	-0.66	0.7	-0.02	0.76	0.68	0.23	0.36	0.33		1.0	-0.22	-0.23
Common Stock	0.36	0.46	0.62	0.56	-0.2	0.62	0.01	-0.77	0.58	0.24	0.76	0.75	0.18	-0.23	-0.59	0.68	-0.06	0.76	0.67	0.2	0.35	0.3	1.0		-0.23	-0.27
Short Term Investments	0.01	-0.39	-0.22	-0.31	0.25	-0.22	-0.04	0.14	0.05	-0.17	-0.02	0.13	0.04	0.01	-0.07	-0.15	-0.13	-0.13	-0.21	0.02	-0.33	0.38	-0.22	-0.23		0.58
Current Deferred Revenue	-0.18	-0.25	-0.47	-0.41	0.17	-0.19	-0.18	0.47	0.06	0.01	-0.28	-0.09	-0.12	-0.22	-0.21	-0.36	0.0	-0.47	-0.39	-0.12	-0.24	0.58	-0.23	-0.27	0.58

Click cells to compare fundamentals

Microbot Medical Account Relationship Matchups

Microbot Medical balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	26.3M	16.8M	9.5M	8.3M	7.5M	7.1M
Short Long Term Debt Total	813K	680K	462K	231K	207.9K	197.5K
Other Current Liab	696K	1.4M	1.7M	3.2M	3.7M	2.6M
Total Current Liabilities	1.3M	2.0M	2.1M	3.8M	4.4M	4.8M
Total Stockholder Equity	24.3M	14.4M	7.3M	4.5M	4.1M	3.8M
Property Plant And Equipment Net	1.0M	888K	723K	406K	365.4K	347.1K
Net Debt	(18.8M)	(12.8M)	(2.0M)	(2.2M)	(2.0M)	(2.1M)
Retained Earnings	(44.3M)	(55.6M)	(68.8M)	(79.5M)	(71.6M)	(75.1M)
Accounts Payable	275K	279K	116K	357K	321.3K	489.2K
Cash	19.7M	13.5M	2.4M	2.5M	2.8M	2.7M
Non Current Assets Total	1.0M	888K	723K	406K	365.4K	347.1K
Non Currrent Assets Other	259K	962K	5.0K	(1.0)	(0.9)	(0.85)
Cash And Short Term Investments	24.6M	15.5M	8.2M	6.4M	7.3M	7.0M
Net Receivables	340K	174K	103K	1.3M	1.5M	1.6M
Common Stock Shares Outstanding	7.1M	7.1M	7.3M	10.2M	11.7M	12.3M
Liabilities And Stockholders Equity	26.3M	16.8M	9.5M	8.3M	7.5M	7.1M
Non Current Liabilities Total	626K	402K	179K	40K	36K	34.2K
Other Current Assets	265K	213K	609K	243K	218.7K	207.8K
Other Stockholder Equity	68.5M	69.9M	76.0M	83.9M	96.5M	101.3M
Total Liab	2.0M	2.4M	2.2M	3.8M	3.4M	3.3M
Total Current Assets	25.3M	15.9M	8.8M	7.9M	7.1M	6.8M
Short Term Debt	374K	278K	283K	191K	219.7K	208.7K
Property Plant And Equipment Gross	251.0	1.2M	1.1M	899K	809.1K	768.6K
Short Term Investments	5.0M	2.0M	5.8M	3.9M	3.5M	3.9M
Inventory	(5K)	(174K)	(103K)	(42K)	(37.8K)	(39.7K)
Net Tangible Assets	31.5M	24.3M	14.4M	7.3M	8.4M	11.1M
Property Plant Equipment	228K	1.0M	888K	723K	650.7K	1.2M
Capital Lease Obligations	813K	680K	462K	231K	265.7K	432.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Microbot Historical Balance Sheet

Microbot Medical Inventory

(39,690)

About Microbot Balance Sheet Analysis

Microbot Medical Balance Sheet Chart

Total Assets

Total Current Liabilities

Microbot Medical balance sheet Correlations

Microbot Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Microbot Medical balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Microbot Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Total Equity
Total Current Assets	+ 0.99	Cash And Short Term Investments
Total Current Assets	+ 0.98	Total Assets
Total Liab	+ 0.98	Non Current Liabilities Total
Cash And Short Term Investments	+ 0.97	Total Assets
Short Term Debt	+ 0.96	Short Long Term Debt Total

Other Stockholder Equity	- 1.0	Retained Earnings
Total Liab	- 0.96	Retained Earnings
Non Current Liabilities Total	- 0.95	Retained Earnings
Net Debt	- 0.93	Total Stockholder Equity
Non Current Assets Total	- 0.91	Retained Earnings
Retained Earnings	- 0.87	Other Current Liab